Currently, there are no approved pharmacological treatments for MCI, although MCI is recognized to provide a window of opportunity to address modifiable risk factors and potentially prevent further progression to dementia [6]
TESAMORELIN Tesamorelin is a synthetic peptide that mimics your bodys natural growth hormone-releasing hormone (GHRH)
CurrPharm Des 26 (25), 29712981
Visual Format: Approved vs investigational status map Key Labels: Cosmetic product, compounded peptide, non-injectable route, injectable route, FDA safety concern, approved drug label, regulatory standards, product category Suggested Layout: Use a horizontal status map with four blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Add a note that product category changes evidence and safety interpretation
Dosing changes when kidney function is low Because the kidneys clear many substances, standard dosing may not apply when your eGFR is reduced
These findings do not constitute proof of efficacy in humans